Information Provided By:
Fly News Breaks for March 29, 2019
MDT, IIN
Mar 29, 2019 | 08:46 EDT
Stifel analyst Jonathan Block said "the past twelve months have certainly been eventful" for IntriCon (IIN) but he contends that the company is "in a much more formidable place than where they were 12 months ago." In terms of potential catalysts over the next twelve months, Block points to a formalization of the company's contract with Medtronic (MDT), changes to the board, the international rollout of 670G and his expectation for a more aggressive Guardian CGM launch in mid-2019. Block, who believes the stock can double from current levels, added IntriCon to the Stifel Select List and keeps a Buy rating and $45 price target on the shares.